ALLMedicine™ Menopause Center
Research & Reviews 6,925 results
https://doi.org/10.1002/pon.5986
Psycho-oncology Renna ME, Shrout MR et. al.
Jun 26th, 2022 - Colorectal cancer poses a significant threat to both psychological and physical health. This study examined relationships between anxiety and depressive symptoms with pain, fatigue, and inflammation among colorectal patients. Colorectal cancer pat...
https://doi.org/10.1016/j.jsxm.2022.03.614
The Journal of Sexual Medicine; Rahmani A, Afsharnia E et. al.
Jun 26th, 2022 - Changes in sex hormones during menopause may have detrimental effects on a woman's sexual function and cause mood disorders. The treatment of both conditions is a challenge in gynecology. To review the published literature on sexual function and m...
https://doi.org/10.1016/j.numecd.2022.06.001
Nutrition, Metabolism, and Cardiovascular Diseases : NMCD; Karppinen JE, Juppi HK et. al.
Jun 26th, 2022 - Menopause may reduce fat oxidation. We investigated whether sex hormone profile explains resting fat oxidation (RFO) or peak fat oxidation (PFO) during incremental cycling in middle-aged women. Secondarily, we studied associations of RFO and PFO w...
https://doi.org/10.1038/s41380-022-01667-8 10.1038/s41562-021-01135-3 10.1038/ng.714 10.1038/nature13545 10.1038/ncomms9464 10.1093/humupd/dmu015 10.1001/jamapsychiatry.2016.0129 10.1038/ng.3551 10.1016/S0140-6736(13)62035-8 10.1016/j.jpag.2015.11.012 10.1007/s10935-014-0344-5 10.1038/npp.2016.153 10.1038/s41588-018-0309-3 10.1093/humupd/dmr026 10.1007/s10680-012-9277-y 10.1093/humrep/dem046 10.1038/ng.3698 10.1038/s41588-018-0144-6 10.1176/appi.ajp.158.10.1568 10.1016/j.janxdis.2014.07.002 10.1016/j.janxdis.2013.04.007 10.1111/pcn.12291 10.1001/archpsyc.62.6.593 10.1002/mpr.1359 10.1192/bjp.bp.108.059485 10.1001/jamapsychiatry.2013.3524 10.31887/DCNS.2015.17.3/dkupfer 10.1017/S1092852916000110 10.1038/mp.2015.197 10.1038/s41380-019-0559-1 10.1038/s41380-019-0590-2 10.1038/mp.2017.154 10.1037/abn0000119 10.1016/j.wombi.2017.06.016 10.1001/jamapsychiatry.2013.4081 10.1093/ije/dyu204 10.1111/jocn.12332 10.1016/j.addbeh.2015.01.039 10.1192/bjp.156.6.809 10.1016/j.psychres.2016.12.053 10.1038/s41467-017-02317-2 10.1093/ije/dyg070 10.1038/s41598-019-48403-x 10.1038/mp.2017.77 10.1038/ng.3211 10.1192/bjp.2019.277 10.1017/S003329171900059X 10.1136/bmj.k601 10.1371/journal.pgen.1007081 10.1016/j.euroneuro.2020.11.003 10.19082/3156 10.1016/j.jad.2005.12.006 10.1093/hmg/ddu150 10.1016/j.jad.2015.11.014 10.1016/j.jad.2015.01.012 10.1186/1471-2458-9-459
Molecular Psychiatry; Ohi K, Kuramitsu A et. al.
Jun 25th, 2022 - Reproductive behaviors are associated with risks for psychiatric disorders. Reproductive phenotypes are moderately heritable and have genetic overlaps with risks for psychiatric disorders. However, the genetic and causal relationships between anxi...
https://doi.org/10.1016/j.seizure.2022.06.004
Seizure Mann C, Zinger E et. al.
Jun 25th, 2022 - Epilepsy is a chronic condition that can affect patients of all ages. Women with epilepsy (WWE) require access to specific counseling and information regarding issues related to contraception, pregnancy, and hormonal effects on seizure control and...
Guidelines 50 results
https://doi.org/10.1016/j.jogc.2021.09.013
Journal of Obstetrics and Gynaecology Canada : JOGC = Jou... Khan AA, Alrob HA et. al.
May 17th, 2022 - Provide strategies for improving the care of perimenopausal and postmenopausal women based on the most recent published evidence. Perimenopausal and postmenopausal women. Target population will benefit from the most recent published scientific evi...
https://academic.oup.com/eurjpc/advance-article/doi/10.1093/eurjpc/zwac060/6580397?login=false
European Journal of Preventive Cardiology; Karppinen JE, .
May 12th, 2022 - We studied the changes in the circulating metabolome and their relation to the menopausal hormonal shift in 17β-oestradiol and follicle-stimulating hormone levels among women transitioning from perimenopause to early postmenopause.
https://doi.org/10.1016/j.jogc.2022.01.012
Journal of Obstetrics and Gynaecology Canada : JOGC = Jou... Robert M, Graves LE et. al.
Apr 12th, 2022 - To provide health care providers with the best evidence on cannabis use with respect to women's health. Areas of focus include general patterns of cannabis use as well as safety of use; care for women who use cannabis; stigma; screening, brief int...
https://doi.org/10.1016/j.euf.2022.01.007
European Urology Focus; Smith M, Dawson S et. al.
Feb 2nd, 2022 - Patients with nocturia are commonly referred to urology clinics, including many for whom a nonurological medical condition is responsible for their symptoms. The PLanning Appropriate Nocturia Evaluation and Treatment (PLANET) study was established...
https://doi.org/10.1016/j.jogc.2021.09.010
Journal of Obstetrics and Gynaecology Canada : JOGC = Jou... Abramson BL, Black DR et. al.
Dec 14th, 2021 - Provide strategies for improving the care of perimenopausal and postmenopausal women based on the most recent published evidence. Perimenopausal and postmenopausal women. Target population will benefit from the most recent published scientific evi...
Drugs 270 results see all →
Clinicaltrials.gov 760 results
https://clinicaltrials.gov/ct2/show/NCT00005902
Jun 24th, 2022 - Hemangioblastomas of the cerebellum, brainstem and spinal cord are frequent tumors in patients with von Hippel-Lindau (VHL) disease. Rarely, these lesions also affect the cerebrum. Patients often have multiple lesions, many of which are associated...
https://clinicaltrials.gov/ct2/show/NCT00001231
Jun 24th, 2022 - Controversy exists regarding the relevance of changes in gonadal steroids for midlife onset depressions. The purpose of this protocol is to allow for the careful screening of patients and healthy volunteers for participation in research protocols ...
https://clinicaltrials.gov/ct2/show/NCT00043472
Jun 24th, 2022 - Background: Annually, more than 25,500 women develop ovarian cancer (OC) and more than 16,000 die of this disease in the United States. Women at high genetic risk of OC have a much higher lifetime risk of developing OC than women in the general po...
https://clinicaltrials.gov/ct2/show/NCT05212376
Jun 24th, 2022 - The population of the study was planned to be composed of menopausal women residing in a village in the north of Turkey. Menopausal women residing in the village were reached from the records of the health unit of the participants. The number of p...
https://clinicaltrials.gov/ct2/show/NCT04124445
Jun 23rd, 2022 - Patients fulfilling eligibility criteria will be randomly allocated to PRF or CRF in a 1:1 ratio. The statistician will use RedCap software to generate random numbers. Patients will be registered to Redcap software and will be concealed from both ...
News 1,844 results
https://www.medscape.com/viewarticle/974118
Jun 24th, 2022 - Menopause is a normal physiologic process diagnosed following the cessation of menses for at least 12 months without a pathological cause. As women grow older, the decline in estrogen levels causes irregular menstrual cycles, until menstruation pe...
https://www.mdedge.com/obgyn/article/255511/menopause/why-do-we-treat-menopause-disease
Marcia Frellick
Jun 17th, 2022 - Menopause gets a bad rap in medical literature and throughout society, say authors of a new analysis. And they argue that the negativity undermines women’s health outlook in the years that should be a natural life transition.
https://www.medscape.com/viewarticle/975711
Jun 16th, 2022 - Dr Genevieve Neal-Perry A phase 3 trial has associated the neurokinin-3 (NK3)–receptor inhibitor fezolinetant, an oral therapy taken once daily, with substantial control over the symptoms of menopause, according to results of the randomized SKYLIG...
https://www.mdedge.com/endocrinology/article/255474/reproductive-endocrinology/nonhormonal-drug-menopause-symptoms-passes
Ted Bosworth
Jun 15th, 2022 - A phase 3 trial has associated the neurokinin-3 (NK3)–receptor inhibitor fezolinetant, an oral therapy taken once daily, with substantial control over the symptoms of menopause, according to results of the randomized SKYLIGHT 2 trial. The nonhormo.
https://www.mdedge.com/obgyn/article/255317/menopause/knowledge-gaps-and-challenges-care-menopausal-women
JoAnn Pinkerton, MD, NCMP
Jun 9th, 2022 - The transition to menopause begins with ovarian fluctuation and hormonal changes, often beginning before significant changes in menstruation. Reproductive aging with loss of follicular activity progresses over a wide age range (42 to 58 years) wit.